Limitations in the Classification of Childhood-onset Rheumatoid Arthritis
Open Access
- 1 February 2014
- journal article
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 41 (3) , 547-553
Abstract
Objective.: Rheumatoid factor-positive polyarthritis (RF+ poly) is the juvenile idiopathic arthritis (JIA) category that resembles adult seropositive rheumatoid arthritis (RA). We studied children with RF+ and/or anticyclic citrullinated peptide antibody (anti-CCP)+ JIA to determine what proportion of those children meet International League of Associations for Rheumatology (ILAR) criteria for RF+ poly JIA and to assess for significant differences between children who meet RF+ poly criteria and those who are classified in other categories.Methods.: Charts of children with JIA who were RF+ and/or anti-CCP+ were reviewed. Children with RF+ poly JIA were compared to children in other categories. Statistical analysis was performed using chi-square, Fisher’s exact test, and the Student’s t-test.Results.: Of 56 children with RF+ and/or anti-CCP+ JIA, 34 (61%) met ILAR criteria for RF+ poly JIA. Twelve children had RF–/anti-CCP+ JIA with low anti-CCP titers. When these 12 children were excluded, there were few significant differences between children who met criteria for RF+ poly and those who were classified in other categories. The American College of Rheumatology/European League Against Rheumatism criteria for RA identified more RF+ children than did the ILAR RF+ poly classification (100% vs 77%).Conclusion.: A number of children with RF+ arthritis were excluded from the RF+ poly JIA classification, though many demographic features and disease measures were similar to those of children who met criteria for RF+ poly JIA. We propose prioritization of RF/anti-CCP positivity over specific exclusions, along with inclusion of anti-CCP, in future revisions of the JIA classification criteria, to improve the sensitivity of diagnosing childhood-onset RA.Keywords
This publication has 12 references indexed in Scilit:
- Anti-cyclic citrullinated peptide (anti-CCP) antibody in juvenile idiopathic arthritis (JIA): Correlations with disease activity and severity of joint damage (a multicenter trial)Joint Bone Spine, 2013
- It is time to rethink juvenile idiopathic arthritis classification and nomenclatureAnnals of the Rheumatic Diseases, 2012
- Anti-CCP antibodies: the past, the present and the futureNature Reviews Rheumatology, 2011
- Early outcomes and improvement of patients with juvenile idiopathic arthritis enrolled in a Canadian multicenter inception cohortArthritis Care & Research, 2010
- Anti-Cyclic Citrullinated Peptide Antibodies in Patients with Juvenile Idiopathic ArthritisImmunological Investigations, 2008
- Meta-analysis: Diagnostic Accuracy of Anti–Cyclic Citrullinated Peptide Antibody and Rheumatoid Factor for Rheumatoid ArthritisAnnals of Internal Medicine, 2007
- Antibodies against cyclic citrullinated peptide are associated with HLA–DR4 in simplex and multiplex polyarticular‐onset juvenile rheumatoid arthritisArthritis & Rheumatism, 2005
- Outcome in adults with juvenile idiopathic arthritis: A quality of life studyArthritis & Rheumatism, 2003
- Radiologic features in juvenile idiopathic arthritis: A first step in the development of a standardized assessment methodArthritis & Rheumatism, 2003
- A study of classification criteria for a diagnosis of juvenile rheumatoid arthritisArthritis & Rheumatism, 1986